In the current work, the use of QT-NPs after induction of colitis played a significant role in the regulation of gene expression related to tight-junction proteins including occludin, MUC-2 and JAM, unlike the DSS-induced colitic non-treated group, which exhibited downregulation of those genes. Here, MUC2 is linked to colitis.